BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.87B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.2B |
| 3 |
Amazon
AMZN
|
+$1.9B |
| 4 |
NVIDIA
NVDA
|
+$1.86B |
| 5 |
Costco
COST
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.53B |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$1.81B |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$732M |
| 4 |
Super Micro Computer
SMCI
|
+$728M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Erasca
ERAS
$6.25B
| $14.4M | ﹤0.01% |
6,981,170
-329,151
| -5% | -$658K |
|
|
BCYC
3127
Bicycle Therapeutics
BCYC
$279M
| $14.3M | ﹤0.01% |
575,030
+73,407
| +15% | +$1.56M |
|
3128
Karyopharm Therapeutics
KPTI
$45.1M
| $14.3M | ﹤0.01% |
629,845
-41,600
| -6% | -$729K |
|
3129
Quantum-Si Incorporated
QSI
$172M
| $14.2M | ﹤0.01% |
7,231,995
-151,576
| -2% | -$265K |
|
3130
Vera Bradley
VRA
$94.7M
| $14.2M | ﹤0.01% |
2,089,284
+45,568
| +2% | +$334K |
|
3131
Organogenesis Holdings
ORGO
$226M
| $14.1M | ﹤0.01% |
4,974,301
-223,886
| -4% | -$761K |
|
|
SYSB
3132
iShares Systematic Bond ETF
SYSB
$1.17B
| $14M | ﹤0.01% |
162,801
| – | – |
|
3133
Ponce Financial Group
PDLB
$501M
| $14M | ﹤0.01% |
1,569,483
-76,607
| -5% | -$686K |
|
|
SLNO
3134
DELISTED
Soleno Therapeutics
SLNO
| $14M | ﹤0.01% |
326,298
+12,637
| +4% | +$572K |
|
3135
Alico
ALCO
$304M
| $13.9M | ﹤0.01% |
475,852
-25,020
| -5% | -$714K |
|
3136
CVRx
CVRX
$78.3M
| $13.9M | ﹤0.01% |
764,999
-38,435
| -5% | -$910K |
|
3137
Zevra Therapeutics
ZVRA
$664M
| $13.9M | ﹤0.01% |
2,397,847
-12,442
| -0.5% | -$76.5K |
|
3138
Magna International
MGA
$18.7B
| $13.9M | ﹤0.01% |
254,655
+366
| +0.1% | +$20.2K |
|
3139
iShares MSCI Kokusai Fund
TOK
$258M
| $13.9M | ﹤0.01% |
128,976
-1
| -0% | -$102 |
|
3140
EverCommerce
EVCM
$1.79B
| $13.8M | ﹤0.01% |
1,468,601
-72,657
| -5% | -$709K |
|
3141
Coca-Cola Femsa
KOF
$22.9B
| $13.8M | ﹤0.01% |
142,203
-87,446
| -38% | -$8.37M |
|
3142
Turkcell
TKC
$4.72B
| $13.7M | ﹤0.01% |
2,637,717
+242,782
| +10% | +$1.27M |
|
3143
Star Holdings Shares of Beneficial Interest
STHO
$117M
| $13.6M | ﹤0.01% |
1,051,101
-45,381
| -4% | -$567K |
|
3144
CS Disco
LAW
$297M
| $13.6M | ﹤0.01% |
1,669,226
-19,686
| -1% | -$151K |
|
3145
Neumora Therapeutics
NMRA
$321M
| $13.6M | ﹤0.01% |
985,571
-58,433
| -6% | -$945K |
|
3146
Praxis Precision Medicines
PRAX
$10.3B
| $13.5M | ﹤0.01% |
221,745
+95,209
| +75% | +$4.27M |
|
3147
Inogen
INGN
$154M
| $13.5M | ﹤0.01% |
1,673,326
-566,998
| -25% | -$4.01M |
|
3148
Algoma Steel
ASTL
$471M
| $13.5M | ﹤0.01% |
1,590,036
+8,955
| +0.6% | +$75.7K |
|
3149
TScan Therapeutics
TCRX
$52.3M
| $13.5M | ﹤0.01% |
1,699,213
+27,486
| +2% | +$173K |
|
|
ITI
3150
DELISTED
Iteris, Inc.
ITI
| $13.4M | ﹤0.01% |
2,722,328
-118,970
| -4% | -$588K |
|
Similar funds
BlackRock's Q1 2024 Portfolio in Review
As of Q1 2024, BlackRock held 5,499 positions worth $4.3T, up 9.5% from $3.92T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BlackRock's Q1 2024 filing shows 129 new, 1,833 increased, 2,801 reduced and 210 closed positions. Its largest new stake was Arcadium Lithium plc: 122,471,992 shares worth $528M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.53B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2024 buy was Arcadium Lithium plc: 122,471,992 shares worth $528M.
- BlackRock added most to Microsoft in Q1 2024, an estimated $2.87B increase.
- BlackRock's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.53B.
- BlackRock fully exited Splunk Inc in Q1 2024, selling an estimated $1.81B.
- BlackRock's ten largest holdings make up 24% of its $4.3T portfolio in Q1 2024.
- BlackRock opened 129 new positions and closed 210 in Q1 2024.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $4.3T.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.